Evaluated articles

Showing page 1144 of 1181 pages of list content

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies

This article has 6 authors:
1. Hao Zhou
2. Belinda M. Dcosta
3. Marie I. Samanovic
4. Mark J. Mulligan
5. Nathaniel R. Landau
6. Takuya Tada
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 31, 2021Latest activity Mar 26, 2021
The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses

This article has 26 authors:
1. Zack Saud
2. Victoria J. Tyrrell
3. Andreas Zaragkoulias
4. Majd B. Protty
5. Evelina Statkute
6. Anzelika Rubina
7. Kirsten Bentley
8. Daniel A. White
9. Patricia Dos Santos Rodrigues
10. Robert C. Murphy
11. Harald Köfeler
12. William J. Griffiths
13. Jorge Alvarez-Jarreta
14. Richard William Brown
15. Robert G. Newcombe
16. James Heyman
17. Manon Pritchard
18. Robert WJ. Mcleod
19. Arvind Arya
20. Ceri-Ann Lynch
21. David Owens
22. P Vince Jenkins
23. Niklaas J. Buurma
24. Valerie B. O’Donnell
25. David W. Thomas
26. Richard J. Stanton
Reviewed by ScreenIT

This article has 3 evaluationsAppears in 1 listLatest version Jun 1, 2022Latest activity Feb 19, 2022
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

This article has 19 authors:
1. Markus Hoffmann
2. Prerna Arora
3. Rüdiger Groß
4. Alina Seidel
5. Bojan F. Hörnich
6. Alexander S. Hahn
7. Nadine Krüger
8. Luise Graichen
9. Heike Hofmann-Winkler
10. Amy Kempf
11. Martin S. Winkler
12. Sebastian Schulz
13. Hans-Martin Jäck
14. Bernd Jahrsdörfer
15. Hubert Schrezenmeier
16. Martin Müller
17. Alexander Kleger
18. Jan Münch
19. Stefan Pöhlmann
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 1, 2021Latest activity Feb 15, 2021
In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays

This article has 6 authors:
1. S.P. Tucker
2. S. Goodall
3. J. Julander
4. M. Mendenhall
5. P. Friedland
6. P.L. Molloy
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 1, 2021Latest activity Feb 19, 2021
SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools

This article has 21 authors:
1. Dan M. Cooper
2. Michael Z. Zulu
3. Allen Jankeel
4. Izabela Coimbra Ibraim
5. Jessica Ardo
6. Kirsten Kasper
7. Diana Stephens
8. Andria Meyer
9. Annamarie Stehli
10. Curt Condon
11. Mary E. Londoño
12. Casey M. Schreiber
13. Nanette V. Lopez
14. Ricky L. Camplain
15. Michael Weiss
16. Charles Golden
17. Shlomit Radom-Aizik
18. Bernadette Boden-Albala
19. Clayton Chau
20. Ilhem Messaoudi
21. Erlinda R. Ulloa
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 24, 2021Latest activity Mar 28, 2021
Value-based pricing of a COVID-19 vaccine

This article has 1 author:
1. Afschin Gandjour
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 1, 2022Latest activity Mar 15, 2021
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

This article has 24 authors:
1. Yiska Weisblum
2. Fabian Schmidt
3. Fengwen Zhang
4. Justin DaSilva
5. Daniel Poston
6. Julio CC Lorenzi
7. Frauke Muecksch
8. Magdalena Rutkowska
9. Hans-Heinrich Hoffmann
10. Eleftherios Michailidis
11. Christian Gaebler
12. Marianna Agudelo
13. Alice Cho
14. Zijun Wang
15. Anna Gazumyan
16. Melissa Cipolla
17. Larry Luchsinger
18. Christopher D Hillyer
19. Marina Caskey
20. Davide F Robbiani
21. Charles M Rice
22. Michel C Nussenzweig
23. Theodora Hatziioannou
24. Paul D Bieniasz
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Oct 28, 2020Latest activity Mar 1, 2021
Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2

This article has 16 authors:
1. Huibin Lv
2. Owen Tak-Yin Tsang
3. Ray T. Y. So
4. Yiquan Wang
5. Meng Yuan
6. Hejun Liu
7. Garrick K. Yip
8. Qi Wen Teo
9. Yihan Lin
10. Weiwen Liang
11. Jinlin Wang
12. Wilson W. Ng
13. Ian A. Wilson
14. J. S. Malik Peiris
15. Nicholas C. Wu
16. Chris K. P. Mok
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 18, 2021Latest activity Mar 1, 2021
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

This article has 13 authors:
1. Tyler N. Starr
2. Allison J. Greaney
3. Sarah K. Hilton
4. Daniel Ellis
5. Katharine H.D. Crawford
6. Adam S. Dingens
7. Mary Jane Navarro
8. John E. Bowen
9. M. Alejandra Tortorici
10. Alexandra C. Walls
11. Neil P. King
12. David Veesler
13. Jesse D. Bloom
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Sep 1, 2020Latest activity Mar 1, 2021
An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

This article has 16 authors:
1. Shiho Tanaka
2. Gard Nelson
3. C. Anders Olson
4. Oleksandr Buzko
5. Wendy Higashide
6. Annie Shin
7. Marcos Gonzalez
8. Justin Taft
9. Roosheel Patel
10. Sofija Buta
11. Ashley Richardson
12. Dusan Bogunovic
13. Patricia Spilman
14. Kayvan Niazi
15. Shahrooz Rabizadeh
16. Patrick Soon-Shiong
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 17, 2021Latest activity Mar 15, 2021
A SIRD model applied to COVID-19 dynamics and intervention strategies during the first wave in Kenya

This article has 3 authors:
1. Wandera Ogana
2. Victor Ogesa Juma
3. Wallace D. Bulimo
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 24, 2021Latest activity Mar 27, 2021
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH

This article has 15 authors:
1. Elena Rensen
2. Stefano Pietropaoli
3. Florian Mueller
4. Christian Weber
5. Sylvie Souquere
6. Sina Sommer
7. Pierre Isnard
8. Marion Rabant
9. Jean-Baptiste Gibier
10. Fabiola Terzi
11. Etienne Simon-Loriere
12. Marie-Anne Rameix-Welti
13. Gérard Pierron
14. Giovanna Barba-Spaeth
15. Christophe Zimmer
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 7, 2022Latest activity Mar 1, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

This article has 44 authors:
1. Leticia Monin
2. Adam G Laing
3. Miguel Muñoz-Ruiz
4. Duncan R McKenzie
5. Irene del Molino del Barrio
6. Thanussuyah Alaguthurai
7. Clara Domingo-Vila
8. Thomas S Hayday
9. Carl Graham
10. Jeffrey Seow
11. Sultan Abdul-Jawad
12. Shraddha Kamdar
13. Elizabeth Harvey-Jones
14. Rosalind Graham
15. Jack Cooper
16. Muhammad Khan
17. Jennifer Vidler
18. Helen Kakkassery
19. Shubhankar Sinha
20. Richard Davis
21. Liane Dupont
22. Isaac Francos Quijorna
23. Charlotte O'Brien-Gore
24. Puay Ling Lee
25. Josephine Eum
26. Maria Conde Poole
27. Magdalene Joseph
28. Daniel Davies
29. Yin Wu
30. Angela Swampillai
31. Bernard V North
32. Ana Montes
33. Mark Harries
34. Anne Rigg
35. James Spicer
36. Michael H Malim
37. Paul Fields
38. Piers Patten
39. Francesca Di Rosa
40. Sophie Papa
41. Timothy Tree
42. Katie J Doores
43. Adrian C Hayday
44. Sheeba Irshad
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 1, 2021Latest activity Mar 24, 2021
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

This article has 12 authors:
1. Alexander Muik
2. Ann-Kathrin Wallisch
3. Bianca Sänger
4. Kena A. Swanson
5. Julia Mühl
6. Wei Chen
7. Hui Cai
8. Daniel Maurus
9. Ritu Sarkar
10. Özlem Türeci
11. Philip R. Dormitzer
12. Uğur Şahin
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Mar 12, 2021Latest activity Jan 28, 2021
Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus

This article has 11 authors:
1. Gemilson Soares Pontes
2. Jean de Melo Silva
3. Renato Pinheiro-Silva
4. Anderson Nogueira Barbosa
5. Luciano Cardenes Santos
6. Antônio de Pádua Quirino Ramalho
7. Carlos Eduardo de Castro Alves
8. Danielle Furtado da Silva
9. Leonardo Calheiros de Oliveira
10. Allyson Guimarães da Costa
11. Ana Carla Bruno
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 2, 2021Latest activity Apr 9, 2021
Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy

This article has 16 authors:
1. Mauro Turrini
2. Angelo Gardellini
3. Livia Beretta
4. Lucia Buzzi
5. Stefano Ferrario
6. Sabrina Vasile
7. Raffaella Clerici
8. Andrea Colzani
9. Luigi Liparulo
10. Giovanni Scognamiglio
11. Gianni Imperiali
12. Giovanni Corrado
13. Antonello Strada
14. Marco Galletti
15. Nunzio Castiglione
16. Claudio Zanon
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 11, 2021Latest activity Mar 15, 2021
Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Detection Testing in Symptomatic and Asymptomatic Children in the Clinical Setting

This article has 13 authors:
1. Arnaud G. L’Huillier
2. Matthieu Lacour
3. Debora Sadiku
4. Mehdi A. Gadiri
5. Loraine De Siebenthal
6. Manuel Schibler
7. Isabella Eckerle
8. Selina Pinösch
9. Laurent Kaiser
10. Alain Gervaix
11. Alban Glangetas
12. Annick Galetto-Lacour
13. Laurence Lacroix
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 18, 2021Latest activity Apr 24, 2021
B.1.1.7 became the dominant variant in Lebanon

This article has 13 authors:
1. Mahmoud Younes
2. Kassem Hamze
3. Daniel P. Carter
4. Karen L. Osman
5. Richard Vipond
6. Miles Carroll
7. Steven T. Pullan
8. Hassan Nassar
9. Nada Mohamad
10. Mohamad Makki
11. Maysaa Ghadar
12. Paul Nguewa
13. Fadi Abdel Sater
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 17, 2021Latest activity Mar 24, 2021
Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests

This article has 11 authors:
1. Jamil N. Kanji
2. Ashley Bailey
3. Jayne Fenton
4. Sean H. Ling
5. Rafael Rivera
6. Sabrina Plitt
7. Wendy I. Sligl
8. Sean Taylor
9. LeeAnn Turnbull
10. Graham Tipples
11. Carmen L. Charlton
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 1, 2021Latest activity Apr 8, 2021
Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants

This article has 15 authors:
1. Bobo Wing-Yee Mok
2. Honglian Liu
3. Siu-Ying Lau
4. Shaofeng Deng
5. Siwen Liu
6. Rachel Chun-Yee Tam
7. Timothy Ting-Leung Ng
8. Jake Siu-Lun Leung
9. Pui Wang
10. Kelvin Kai-Wang To
11. Jasper Fuk-Woo Chan
12. Kwok-Hung Chan
13. Kwok-Yung Yuen
14. Gilman Kit-Hang Siu
15. Honglin Chen
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 19, 2021Latest activity Apr 24, 2021